The study found that the levels of INR, prothrombin time, and activated thromboplastin time were significantly longer in the death group of COVID-19 individuals compared with the healthy control group, and the rate increased with the severity of COVID-19 infection in the in-hospital individuals. The gene discussed is F2; the disease is COVID-19.